A Retrospective Study to Characterize Participants With Propionic Acidemia
Part of paid clinical trials in Stanford, California.
- Sponsor
- ModernaTX, Inc.
- Study ID
- NCT05769621
- Status
- Recruiting
Conditions
- Propionic Acidemia
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This is a non-interventional, observational, global, multicenter, study describing participant characteristics, clinical outcomes, and event rates in participants with propionic acidemia (PA).
Key Dates
- Start date
- Jun 16, 2023
- Status verified
- Feb 2026
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 60 participants (estimated)
Arms
- Arm: PA ParticipantsParticipants with PA who meet all eligibility criteria for medical record abstraction.
Primary Outcome Measure
Number of Annualized Clinical Event Committee (CEC)-adjudicated Metabolic Decompensation Events (MDEs) [ Time Frame: Up to 10 years ]
Central Contacts
- Moderna WeCare Team+1-866-663-3762
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Stanford Medical Center | Stanford | California | 94305-2200 | - |
| Johns Hopkins University | Baltimore | Maryland | 21287-0010 | - |
| University of Michigan Hospital | Ann Arbor | Michigan | 48109-5000 | - |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | - |
| Texas Children's Hospital | Houston | Texas | 77030-2614 | - |
| Seattle Children's Hospital | Seattle | Washington | 98105-3901 | - |
Find similar trials in Stanford, CA
Related Studies
- Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic AcidemiaRecruiting · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland
- Open-Label Study of mRNA-3927 in Participants With Propionic AcidemiaPHASE1/PHASE2 · Recruiting · ModernaTX, Inc. · Los Angeles, California
- A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 StudyPHASE1/PHASE2 · Recruiting · ModernaTX, Inc. · Los Angeles, California
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina